The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

IJMS, Free Full-Text

IJMS, Free Full-Text

ROS1-dependent cancers — biology, diagnostics and therapeutics

PDF] Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients

Full article: The CLIP1–LTK fusion: anew oncogenic driver in non

PDF] Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

Frontiers Neoadjuvant therapy in non-small cell lung cancer

Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)